(Total Views: 483)
Posted On: 01/17/2021 7:43:33 PM
Post# of 148908
I think that is plausible. Which makes me wonder:
If SOC has reduced mortality in the placebo arm, it should also reduce mortality in the treatment arm, right?
So if placebo is 26%, in order to hit the 87 deaths figure, Leronlimab would be 20%, which would mean it's higher than the EIND, which doesn't make sense.
However if a decent number of the 87 are outside of 28 days, the treatment arm % would reduce.
If SOC has reduced mortality in the placebo arm, it should also reduce mortality in the treatment arm, right?
So if placebo is 26%, in order to hit the 87 deaths figure, Leronlimab would be 20%, which would mean it's higher than the EIND, which doesn't make sense.
However if a decent number of the 87 are outside of 28 days, the treatment arm % would reduce.
(0)
(0)Scroll down for more posts ▼
